Today: 25 January 2026
Subscribe

Khadija Saeed

A dedicated markets reporter, she covers stocks, macroeconomics, and major business developments with a sharp eye for detail and accuracy.

RTX Stock Forecast for December 2025: New Billion‑Dollar Defense Deals, AWS Tie‑Up and Analyst Upgrades Explained

RTX Stock Forecast for December 2025: New Billion‑Dollar Defense Deals, AWS Tie‑Up and Analyst Upgrades Explained

Updated: December 4, 2025 – Ticker: RTX (NYSE: RTX) RTX Corporation, the aerospace and defense giant formerly known as Raytheon Technologies, is back in the market’s spotlight in early December 2025. A string of fresh contracts, a new cloud collaboration with Amazon Web Services (AWS), and broadly positive analyst sentiment are shaping the latest RTX stock forecast – just as…
4 December 2025
···
Linde Stock on December 4, 2025: Credit Agreement, 52‑Week Low and Analyst Forecasts for LIN in 2026

Linde Stock on December 4, 2025: Credit Agreement, 52‑Week Low and Analyst Forecasts for LIN in 2026

As of December 4, 2025, Linde plc (NASDAQ: LIN) is trading near a 52‑week low despite resilient earnings, a fresh credit agreement and a growing dividend — setting up a nuanced risk–reward profile for investors watching Linde stock and LIN forecasts for 2026. Linde at a glance Linde plc is the world’s largest industrial gases and engineering company, supplying oxygen,…
4 December 2025
···
RTX Stock Forecast for December 2025: New Billion‑Dollar Defense Deals, AWS Tie‑Up and Analyst Upgrades Explained

RTX Stock Forecast for December 2025: New Billion‑Dollar Defense Deals, AWS Tie‑Up and Analyst Upgrades Explained

Updated: December 4, 2025 – Ticker: RTX (NYSE: RTX) RTX Corporation, the aerospace and defense giant formerly known as Raytheon Technologies, is back in the market’s spotlight in early December 2025. A string of fresh contracts, a new cloud collaboration with Amazon Web Services (AWS), and broadly positive analyst sentiment are shaping the latest RTX stock forecast – just as…
4 December 2025
···
Merck (MRK) Stock Outlook on December 4, 2025: Dividend Hike, Legal Setback and New Growth Drivers

Merck (MRK) Stock Outlook on December 4, 2025: Dividend Hike, Legal Setback and New Growth Drivers

As of the close on December 4, 2025, Merck & Co., Inc. (NYSE: MRK) shares finished at $100.86, down about 1.4% on the day, with after‑hours trading essentially flat around $100.83. The stock sits near the upper end of its 52‑week range of $73.31–$105.84, with a market value of roughly $250 billion, a trailing P/E around 13.3 and a forward…
4 December 2025
···
Coca-Cola (KO) Stock Outlook December 2025: Dividend King Faces Lawsuit Risk but Analysts Still See Upside

Coca-Cola (KO) Stock Outlook December 2025: Dividend King Faces Lawsuit Risk but Analysts Still See Upside

Data and news current through the close on December 4, 2025. This article is for informational purposes only and is not investment advice. Coca-Cola stock today: price, performance and valuation The Coca-Cola Company (NYSE: KO) closed at $70.54 on December 4, 2025, down about 0.37% for the day. Intraday, shares traded between $70.45 and $71.34 on volume of roughly 8.4…
4 December 2025
····
Intuit (INTU) Stock Outlook December 4, 2025: AI Partnership With OpenAI, Earnings Beat and Wall Street Targets Explained

Intuit (INTU) Stock Outlook December 4, 2025: AI Partnership With OpenAI, Earnings Beat and Wall Street Targets Explained

Intuit Inc. (NASDAQ: INTU) is back in the spotlight after a powerful fiscal Q1 earnings beat, a multi‑year $100M+ AI partnership with OpenAI, and fresh institutional buying – all against a backdrop of rich valuation and mixed sentiment on near‑term guidance. Below is a detailed look at where Intuit stock stands as of December 4, 2025, including the latest news,…
4 December 2025
····
MercadoLibre (MELI) Stock on December 4, 2025: Bond Deal, New BTIG Price Target and Rising Short Interest – Does 30% Upside Still Hold?

MercadoLibre (MELI) Stock on December 4, 2025: Bond Deal, New BTIG Price Target and Rising Short Interest – Does 30% Upside Still Hold?

As of Thursday, December 4, 2025, MercadoLibre, Inc. (NASDAQ: MELI) is trading around $2,140 per share, leaving the Latin American e‑commerce and fintech giant roughly 19% below its 2025 all‑time high near $2,645 and comfortably above its 52‑week low around $1,646. Investing.com At the same time, Wall Street is doubling down on bullish forecasts, with BTIG reiterating a Buy rating…
4 December 2025
···
DoorDash Stock (DASH) on December 4, 2025: Insider Buying, Analyst Targets and the Amazon Threat

DoorDash Stock (DASH) on December 4, 2025: Insider Buying, Analyst Targets and the Amazon Threat

Updated: December 4, 2025 DoorDash, Inc. (DASH) remains one of the most hotly debated growth stocks in the market. On December 4, 2025, shares trade around $222, giving the company a market capitalization near $96 billion and a rich price-to-earnings ratio of roughly 116 based on trailing earnings. StockAnalysis Year to date, DoorDash stock is up about 30–33%, comfortably ahead…
4 December 2025
····
Danaher (DHR) Stock on December 4, 2025: Analyst Upgrades, Q3 Beat and Governance Probes Shape the 2026 Outlook

Danaher (DHR) Stock on December 4, 2025: Analyst Upgrades, Q3 Beat and Governance Probes Shape the 2026 Outlook

Danaher Corporation (NYSE: DHR) is back in the spotlight on December 4, 2025, as fresh bullish research, new institutional buying, and a high‑profile Morgan Stanley upgrade collide with a series of governance investigations into the company’s board. At the same time, Danaher’s own guidance points to a 2026 recovery built on mid‑single‑digit revenue growth and expanding margins. As of Thursday…
4 December 2025
····
Johnson & Johnson (JNJ) Stock on December 4, 2025: Price Action, Latest News, Analyst Targets and 2026 Outlook

Johnson & Johnson (JNJ) Stock on December 4, 2025: Price Action, Latest News, Analyst Targets and 2026 Outlook

Published: December 4, 2025 Johnson & Johnson (NYSE: JNJ) remains one of 2025’s standout defensive stocks. After a powerful run driven by stronger pharma growth, MedTech momentum and a string of acquisitions, the healthcare giant now trades close to record highs while still offering a solid dividend and relatively low volatility. At the same time, investors watching JNJ today must…
4 December 2025
···
Hims & Hers (HIMS) Stock Jumps on Canada Launch and YourBio Deal: Latest News, Forecasts and Analysis for December 4, 2025

Hims & Hers (HIMS) Stock Jumps on Canada Launch and YourBio Deal: Latest News, Forecasts and Analysis for December 4, 2025

Hims & Hers Health, Inc. (NYSE: HIMS) is back in the spotlight. In Thursday’s session on December 4, 2025, the telehealth stock climbed roughly 5–8%, trading around $40 and valuing the company at about $12.8 billion, after a flurry of strategic announcements. Finviz The immediate catalysts: At the same time, fresh coverage from MarketBeat, TipRanks, Zacks and others is revisiting…
4 December 2025
···
Adobe Inc. (ADBE) Stock on December 4, 2025: AI Jitters, New Deals and Q4 Earnings Hopes – Is the Selloff Overdone?

Adobe Inc. (ADBE) Stock on December 4, 2025: AI Jitters, New Deals and Q4 Earnings Hopes – Is the Selloff Overdone?

Data and news in this article are current as of December 4, 2025. Figures may change as markets move. Adobe stock today: price, performance and valuation Adobe shares were recently trading around $328 per share, giving the company a market value of roughly $137–138 billion. TradingView Over the past year, the stock has had a rough ride: On valuation, multiple…
4 December 2025
····
1 … 726 727 728 729 730 … 812

Stock Market Today

  • St Barbara (ASX:SBM) Shares Surge on Nova Scotia Project Study, Valuation Split Evident
    January 25, 2026, 5:57 AM EST. St Barbara (ASX:SBM) has risen sharply, gaining 8.45% in one day and 38.74% over seven days, following the completion of a Pre Feasibility Study for its 15 Mile Processing Hub Project in Nova Scotia. Despite recent losses of A$54.6 million, the company shows promise with forecasted 23.7% annual revenue growth and potential profitability within three years. The stock trades at A$0.77, above a projected fair price-to-sales (P/S) ratio of 1x, yet below the Australian metals and mining sector's average P/S of 144.6x. Valuations diverge sharply; a discounted cash flow (DCF) model suggests shares are undervalued by approximately 87% against a fair value of A$5.89. Investors face risks including operations at the Simberi mine in Papua New Guinea, but strong longer-term total shareholder returns provide context for the recent price momentum.
Go toTop